West Pharmaceutical Services (NYSE:WST) will post its quarterly earnings results before the market opens on Wednesday, February 14th. Analysts expect West Pharmaceutical Services to post earnings of $0.63 per share for the quarter.

Shares of West Pharmaceutical Services (NYSE WST) opened at $91.25 on Monday. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15. West Pharmaceutical Services has a 52 week low of $77.97 and a 52 week high of $103.36. The stock has a market capitalization of $6,780.00, a PE ratio of 36.35, a price-to-earnings-growth ratio of 1.94 and a beta of 1.04.

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 1st. Shareholders of record on Thursday, January 18th were paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date of this dividend was Wednesday, January 17th. West Pharmaceutical Services’s payout ratio is 22.31%.

A number of analysts have issued reports on the company. Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $115.00 price target on the stock in a research note on Saturday, February 3rd. Goldman Sachs Group assumed coverage on West Pharmaceutical Services in a research note on Wednesday, January 24th. They issued a “neutral” rating and a $110.00 price target on the stock. Wells Fargo & Co raised their price target on West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a research note on Friday, October 27th. Finally, Bank of America downgraded West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price objective on the stock. in a report on Tuesday, October 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $108.17.

In other news, CFO William J. Federici sold 21,000 shares of the firm’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $99.01, for a total value of $2,079,210.00. Following the transaction, the chief financial officer now directly owns 190,493 shares in the company, valued at approximately $18,860,711.93. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://theolympiareport.com/2018/02/12/west-pharmaceutical-services-wst-scheduled-to-post-earnings-on-wednesday.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Earnings History for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.